ES529349A0 - Un procedimiento para la preparacion de derivados de acilmorfinano - Google Patents

Un procedimiento para la preparacion de derivados de acilmorfinano

Info

Publication number
ES529349A0
ES529349A0 ES529349A ES529349A ES529349A0 ES 529349 A0 ES529349 A0 ES 529349A0 ES 529349 A ES529349 A ES 529349A ES 529349 A ES529349 A ES 529349A ES 529349 A0 ES529349 A0 ES 529349A0
Authority
ES
Spain
Prior art keywords
acilmorfinan
derivatives
procedure
preparation
acilmorfinan derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES529349A
Other languages
English (en)
Other versions
ES8506635A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8506635A1 publication Critical patent/ES8506635A1/es
Publication of ES529349A0 publication Critical patent/ES529349A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ES529349A 1981-11-09 1984-02-01 Un procedimiento para la preparacion de derivados de acilmorfinano Granted ES529349A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/319,482 US4374139A (en) 1981-11-09 1981-11-09 Levorotatory N-substituted acylmorphinans useful as analgesic agents

Publications (2)

Publication Number Publication Date
ES8506635A1 ES8506635A1 (es) 1985-08-01
ES529349A0 true ES529349A0 (es) 1985-08-01

Family

ID=23242421

Family Applications (2)

Application Number Title Priority Date Filing Date
ES517222A Granted ES517222A0 (es) 1981-11-09 1982-11-08 Un procedimiento para la preparacion de derivados de acilmorrfinano.
ES529349A Granted ES529349A0 (es) 1981-11-09 1984-02-01 Un procedimiento para la preparacion de derivados de acilmorfinano

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES517222A Granted ES517222A0 (es) 1981-11-09 1982-11-08 Un procedimiento para la preparacion de derivados de acilmorrfinano.

Country Status (18)

Country Link
US (1) US4374139A (es)
EP (1) EP0079556A3 (es)
JP (1) JPS5888364A (es)
KR (1) KR840002357A (es)
AU (1) AU9027682A (es)
CA (1) CA1195324A (es)
DK (1) DK491582A (es)
ES (2) ES517222A0 (es)
FI (1) FI823824L (es)
GR (1) GR78317B (es)
HU (1) HU187425B (es)
IL (1) IL67180A0 (es)
MC (1) MC1490A1 (es)
NO (1) NO823707L (es)
NZ (1) NZ202404A (es)
PH (1) PH18458A (es)
PT (1) PT75815B (es)
ZA (1) ZA827905B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423221A (en) * 1982-06-10 1983-12-27 Sisa Pharmaceutical Laboratories, Inc. 7-Carboethoxy-morphinan-6-one compounds
US4454141A (en) * 1982-09-23 1984-06-12 Sisa Pharmaceutical Laboratories, Inc. Trans-B/C-7-(1-hydroxypentyl)-3-methoxy-17 methyl-6,7-didehydromorphinans, and methods of relieving pain with them
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
DE4304450A1 (de) * 1993-02-13 1994-08-18 Boehringer Mannheim Gmbh System zur Zubereitung von Flüssigkeiten
AU2002227135B2 (en) * 2000-10-31 2008-01-03 Rensselaer Polytechnic Institute 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
JP4202250B2 (ja) 2001-07-25 2008-12-24 バイオマリン ファーマシューティカル インコーポレイテッド 血液脳関門輸送を調節するための組成物および方法
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
EP2671507A3 (en) 2005-04-28 2014-02-19 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2752373C (en) 2009-02-20 2017-10-10 To-Bbb Holding B.V. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
TR201908514T4 (tr) 2009-12-04 2019-07-22 Alkermes Pharma Ireland Ltd İlaç doz aşimi tedavi̇si̇ i̇çi̇n morfi̇nan türevleri̇
US8436175B2 (en) 2010-03-22 2013-05-07 Rensselaer Polytechnic Institute Carboxamide bioisosteres of opiates
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2013003720A1 (en) 2011-06-29 2013-01-03 Alkermes, Inc. Peripherally acting opioid compounds
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
ES2770978T3 (es) 2013-05-24 2020-07-06 Alkermes Pharma Ireland Ltd Análogos de morfanos y morfinanos y métodos de uso
EP3003311A2 (en) 2013-05-24 2016-04-13 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
EP4243768A1 (en) 2020-11-12 2023-09-20 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723437A (en) * 1970-09-15 1973-03-27 American Home Prod 4,10-(methaniminomethano phenanthrene derivatives
ZA73988B (en) * 1972-03-10 1973-10-31 Hoffmann La Roche Morphinan derivatives
US3914233A (en) * 1972-10-20 1975-10-21 Hoffmann La Roche 4-Hydroxy-N-substituted morphinan derivatives

Also Published As

Publication number Publication date
MC1490A1 (fr) 1983-09-12
KR840002357A (ko) 1984-06-25
PT75815A (en) 1982-12-01
GR78317B (es) 1984-09-26
EP0079556A3 (de) 1983-08-24
US4374139A (en) 1983-02-15
NZ202404A (en) 1985-11-08
DK491582A (da) 1983-05-10
JPS5888364A (ja) 1983-05-26
FI823824A0 (fi) 1982-11-08
PH18458A (en) 1985-07-18
ES8506635A1 (es) 1985-08-01
HU187425B (en) 1986-01-28
CA1195324A (en) 1985-10-15
ES8500948A1 (es) 1984-12-01
ES517222A0 (es) 1984-12-01
ZA827905B (en) 1983-08-31
FI823824A7 (fi) 1983-05-10
EP0079556A2 (de) 1983-05-25
IL67180A0 (en) 1983-03-31
PT75815B (en) 1986-01-21
FI823824L (fi) 1983-05-10
NO823707L (no) 1983-05-10
AU9027682A (en) 1983-05-19

Similar Documents

Publication Publication Date Title
ES517542A0 (es) Un procedimiento para la preparacion de derivados de 3-hidroxi-ml-236-b.
ES504103A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES502994A0 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
ES502792A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES529349A0 (es) Un procedimiento para la preparacion de derivados de acilmorfinano
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES514264A0 (es) Un procedimiento para la preparacion de derivados de tiazolidi-nilalquilen-piperazinas.
ES524922A0 (es) Un procedimiento para la preparacion de nuevos derivados de 3-amino-pregn-5-eno
ES512880A0 (es) Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina.
ES509437A0 (es) Un procedimiento para la preparacion de derivados carbapenen-2-tio-sustituidos.
ES524399A0 (es) Un procedimiento para la preparacion de derivados de milbenicina d
ES513880A0 (es) Un procedimiento para la preparacion de derivados de triazolurea.
ES536982A0 (es) Un procedimiento para la preparacion de un derivado de carbostirilo
ES515655A0 (es) Un procedimiento para la preparacion de derivados de benzotiazolina.
ES513967A0 (es) Un procedimiento para la preparacion de derivados de etanola-mina.
ES510611A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina.
ES518347A0 (es) Un procedimiento para la preparacion de derivados de desoxiuridina
ES515988A0 (es) Un procedimiento para la preparacion de nuevos derivados bencilicos trisustituidos
ES526149A0 (es) Un procedimiento para la preparacion de derivados de espirotiazolidinil-piperazina
ES540344A0 (es) Un procedimiento para la preparacion de derivados de piperi-dina
ES500911A0 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES527804A0 (es) Un procedimiento para la preparacion de derivados de oxacefalosporina
ES508775A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hepteno.
ES498145A0 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
ES517852A0 (es) Un procedimiento para la preparacion de derivados de bencenosulfonamidas.